{"id":"https://openalex.org/A5014192055","orcid":"https://orcid.org/0000-0001-6805-5815","observed_orcids":["https://orcid.org/0000-0001-6805-5815"],"display_name":"Patrick Younan","raw_author_names":["Patrick Younan"],"full_name":"Patrick Younan","works_count":21,"cited_by_count":103,"summary_stats":{"2yr_mean_citedness":0.11764705882352941,"h_index":3,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5014192055","orcid":"https://orcid.org/0000-0001-6805-5815","observed_orcids":["https://orcid.org/0000-0001-6805-5815"]},"affiliations":[{"institution":{"id":"https://openalex.org/I99319750","ror":"https://ror.org/01vwesc15","display_name":"Seagen (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]},"years":[2026,2023,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I99319750","ror":"https://ror.org/01vwesc15","display_name":"Seagen (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":19,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","count":15,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","count":14,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":9,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","count":2,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","value":5.01e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":4.26e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","value":3.68e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11150","display_name":"Endoplasmic Reticulum Stress and Disease","value":2.75e-05,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","value":1.93e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2778191690","wikidata":"https://www.wikidata.org/wiki/Q422324","display_name":"Brentuximab vedotin","score":0.9843603372573853},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.6456074714660645},{"id":"70905583","wikidata":"https://www.wikidata.org/wiki/Q3648608","display_name":"CD30","score":0.5622642636299133},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.45344334840774536},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.36076873540878296}],"counts_by_year":[{"year":2022,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2023,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2024,"works_count":16,"oa_works_count":16,"cited_by_count":21},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":35},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":47}],"display_name_alternatives":["Patrick Younan"],"block_key":"p younan","works_api_url":"https://api.openalex.org/works?filter=author.id:A5014192055","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5014192055","updated_date":"2026-11-12T13:17:38","created_date":"2022-11-11T00:00:00"}